SCHEMBL6922467

SCHEMBL6922467

Cc1cccc(C)c1COc1nccn2c(C)c(C)nc12

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 12/20 0.66
CYP2C9 P11712 12/20 0.66
CYP2C19 P33261 6/20 0.66
CYP1A2 P05177 6/20 0.66
CYP2D6 P10635 6/20 0.66
ATP4A P20648 1/20 0.53
ATP4B P51164 1/20 0.53
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
FLT1 P17948 1/20 0.37
CDK8 P49336 1/20 0.37
CDK9 P50750 1/20 0.37
LIMK1 P53667 1/20 0.37
ROCK1 Q13464 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10918911 0.82 ATP4A (0.76) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL7499341 0.80 CYP3A4 (1.00) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6926551 0.75 CYP3A4 (0.63) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL8803895 0.72 CYP3A4 (0.83) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL7216941 0.71 CYP3A4 (0.81) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL4891085 0.70 CYP3A4 (0.65) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL4888948 0.70 CYP3A4 (0.54) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL7984904 0.69 ATP4A (0.73) CYP3A4CYP2C9CYP1A2CYP2D6ATP4A
SCHEMBL2192969 0.69 ATP4A (1.00) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL11001197 0.69 ATP4A (0.73) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042324-B1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF ASTRAZENECA AB (SE) 2003-02-26 EP claimed
US-6518270-B1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof ASTRAZENECA AB (SE) 2003-02-11 US claimed
EP-1042324-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF AstraZeneca AB (SE) 2000-10-11 EP claimed
WO-1999028322-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF ASTRAZENECA AB (SE) 1999-06-10 WO claimed
EP-1042324-B1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF ASTRAZENECA AB (SE) 2003-02-26 EP disclosed
US-6518270-B1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof ASTRAZENECA AB (SE) 2003-02-11 US disclosed
EP-1042324-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF AstraZeneca AB (SE) 2000-10-11 EP disclosed
WO-1999028322-A1 HETEROCYCLIC COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF ASTRAZENECA AB (SE) 1999-06-10 WO disclosed